Natalizumab vs fingolimod in patients with active relapsing-remitting multiple sclerosis (RRMS): comparative MRI assessments of disease activity from reveal, a randomized, head-to-head phase 4 study

著录项

• 来源
  《Journal of the Neurological Sciences: Official Bulletin of the World Federation of Neurology》 |2017年第2017期|共1页
• 作者

  S. Licata; H. Butzkueven; D. Jeffery; D.L. Arnold; M. Filippi; J.J.G. Geurts; Q. Dong; N. Campbell; P.R. Ho;

  展开▼
• 作者单位

  Biogen Global Medical Affairs;

  University of Melbourne- Royal Melbourne Hospital Department of Medicine and Melbourne Brain;

  Piedmont HealthCare;

  Montreal Neurological Institute NeuroRx Research;

  Vita-Salute San Raffaele University Neuroimaging Research Unit Institute of Experimental;

  VU University Medical Center Department of Anatomy and Neuroscience- Section of Clinical;

  Biogen Biostatistics;

  Biogen Global Medical Affairs;

  Biogen Global Medical Affairs;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 神经病学;
• 关键词

• 入库时间 2022-08-19 19:52:28